Patents by Inventor John R. Jenkins

John R. Jenkins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140024811
    Abstract: Provided are methods of detecting cancer or pre-cancerous conditions in patients comprising assaying a patient sample for an elevated level of target molecules representative of expression of nucleosome assembly protein 1-like 1 (NAP1L1), wherein elevated levels of expression of NAP1L1 are indicative of a cancer of the colon, or a precancerous condition of the colon. Also provided are similar methods using panels of biomarkers such as HMGB1; PHB; RPL6; NAP1L1 and CK18. The invention also provides a method for assessing effectiveness of a therapy or putative therapy, methods of staging cancer and assessing progression of a cancer and methods of determining an appropriate cancer treatment regimen.
    Type: Application
    Filed: March 29, 2012
    Publication date: January 23, 2014
    Applicant: THE UNIVERSITY OF LIVERPOOL
    Inventor: John R. Jenkins
  • Patent number: 7223550
    Abstract: A biosensor for the identification of olfactants, including chemical and biological agents, prefumery, explosives and pharmaceuticals. The biosensors comprise robust eukaryotic cells, such as yeast, into which at least one exogenous olfactory signaling pathway has been genetically integrated to detect molecules of interest.
    Type: Grant
    Filed: February 8, 2002
    Date of Patent: May 29, 2007
    Assignee: Temple University-of the Commonwealth System of Higher Education
    Inventors: Natarajan Dhanasekaran, John R. Jenkins
  • Publication number: 20040235060
    Abstract: A biosensor for the identification of olfactants, including chemical and biological agents, perfumery, explosives and pharmaceuticals. The biosensors comprise robust eukaryotic cells, such as yeast, into which at least one exogenous olfactory signaling pathway has been genetically integrated to detect molecules of interest.
    Type: Application
    Filed: June 25, 2004
    Publication date: November 25, 2004
    Inventors: Natarajan Dhanasekaran, John R Jenkins
  • Publication number: 20040203067
    Abstract: The invention provides prognostic methods which comprise determining the level of expression of the gene c-fyn, or the level of activated STAT-3 protein. Because the relative level of c-fyn expression and level of activated STAT-3 protein correlate with the presence of malignant potential and therefore patient prognosis, these markers may be used to make treatment decisions, to predict patient outcome, and to predict the risk of cancer in disease-free individuals. The invention further provides a method for identifying anticancer drugs in which inhibitors of cell proliferation are identified as inhibitors of Src-mediated STAT phosphorylation.
    Type: Application
    Filed: May 13, 2004
    Publication date: October 14, 2004
    Applicant: Temple University - Of The Commonwealth System of Higher Education
    Inventors: E. Premkumar Reddy, Priya Chaturvedi, M.V. Ramana Reddy, John R. Jenkins
  • Patent number: D743775
    Type: Grant
    Filed: September 19, 2014
    Date of Patent: November 24, 2015
    Assignee: UNIVERSITY OF HOUSTON
    Inventor: John R. Jenkins